26
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Anti-inflammatory Effects of Heme Oxygenase-1 Depend on Adenosine A 2A- and A 2B-Receptor Signaling in Acute Pulmonary Inflammation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Acute pulmonary inflammation is still a frightening complication in intensive care units. In our previous study, we determined that heme oxygenase (HO)-1 had anti-inflammatory effects in pulmonary inflammation. Recent literature has emphasized a link between HO-1 and the nucleotide adenosine. Since adenosine A 2A- and A 2B-receptors play a pivotal role in pulmonary inflammation, we investigated their link to the enzyme HO-1. In a murine model of pulmonary inflammation, the activation of HO-1 by hemin significantly decreased polymorphonuclear leukocyte (PMN) migration into the lung. This anti-inflammatory reduction of PMN migration was abolished in A 2A- and A 2B-knockout mice. Administration of hemin significantly reduced chemokine levels in the BAL of wild-type animals but had no effects in A 2A -/- and A 2B -/- mice. Microvascular permeability was significantly attenuated in HO-1-stimulated wild-type mice, but not in A 2A -/- and A 2B -/- mice. The activity of HO-1 rose after LPS inhalation in wild-type animals and, surprisingly, also in A 2A -/- and A 2B -/- mice after the additional administration of hemin. Immunofluorescence images of animals revealed alveolar macrophages to be the major source of HO-1 activity in both knockout strains—in contrast to wild-type animals, where HO-1 was also significantly augmented in the lung tissue. In vitro studies on PMN migration further confirmed our in vivo findings. In conclusion, we linked the anti-inflammatory effects of HO-1 to functional A 2A/A 2B-receptor signaling under conditions of pulmonary inflammation. Our findings may explain why targeting HO-1 in acute pulmonary inflammation has failed to prove effective in some patients, since septic patients have altered adenosine receptor expression.

          Related collections

          Most cited references60

          • Record: found
          • Abstract: found
          • Article: not found

          Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway.

          The stress-inducible protein heme oxygenase-1 provides protection against oxidative stress. The anti-inflammatory properties of heme oxygenase-1 may serve as a basis for this cytoprotection. We demonstrate here that carbon monoxide, a by-product of heme catabolism by heme oxygenase, mediates potent anti-inflammatory effects. Both in vivo and in vitro, carbon monoxide at low concentrations differentially and selectively inhibited the expression of lipopolysaccharide-induced pro-inflammatory cytokines tumor necrosis factor-alpha, interleukin-1beta, and macrophage inflammatory protein-1beta and increased the lipopolysaccharide-induced expression of the anti-inflammatory cytokine interleukin-10. Carbon monoxide mediated these anti-inflammatory effects not through a guanylyl cyclase-cGMP or nitric oxide pathway, but instead through a pathway involving the mitogen-activated protein kinases. These data indicate the possibility that carbon monoxide may have an important protective function in inflammatory disease states and thus has potential therapeutic uses.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Nucleotide signalling during inflammation.

            Inflammatory conditions are associated with the extracellular release of nucleotides, particularly ATP. In the extracellular compartment, ATP predominantly functions as a signalling molecule through the activation of purinergic P2 receptors. Metabotropic P2Y receptors are G-protein-coupled, whereas ionotropic P2X receptors are ATP-gated ion channels. Here we discuss how signalling events through P2 receptors alter the outcomes of inflammatory or infectious diseases. Recent studies implicate a role for P2X/P2Y signalling in mounting appropriate inflammatory responses critical for host defence against invading pathogens or tumours. Conversely, P2X/P2Y signalling can promote chronic inflammation during ischaemia and reperfusion injury, inflammatory bowel disease or acute and chronic diseases of the lungs. Although nucleotide signalling has been used clinically in patients before, research indicates an expanding field of opportunities for specifically targeting individual P2 receptors for the treatment of inflammatory or infectious diseases.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Heme oxygenase-1: unleashing the protective properties of heme.

              Heme oxygenase (HO)-1 catabolizes heme into three products: carbon monoxide (CO), biliverdin (which is rapidly converted to bilirubin) and free iron (which leads to the induction of ferritin, an iron-binding protein). HO-1 serves as a "protective" gene by virtue of the anti-inflammatory, anti-apoptotic and anti-proliferative actions of one or more of these three products. Administration of CO, biliverdin, bilirubin or iron-binding compounds is protective in rodent disease models of ischemia-reperfusion injury, allograft and xenograft survival, intimal hyperplasia following balloon injury or as seen in chronic graft rejection and others. We suggest that the products of HO-1 action could be valuable therapeutic agents and speculate that HO-1 functions as a "therapeutic funnel", mediating the beneficial effects attributed to other molecules, such as interleukin-10 (IL-10), inducible nitric oxide synthase (NOS2; iNOS) and prostaglandins. This Review is the third in a series on the regulation of the immune system by metabolic pathways.
                Bookmark

                Author and article information

                Contributors
                URI : http://frontiersin.org/people/u/474373
                URI : http://frontiersin.org/people/u/501305
                URI : http://frontiersin.org/people/u/487236
                Journal
                Front Immunol
                Front Immunol
                Front. Immunol.
                Frontiers in Immunology
                Frontiers Media S.A.
                1664-3224
                20 December 2017
                2017
                : 8
                : 1874
                Affiliations
                [1] 1Department of Anesthesiology and Intensive Care Medicine, University Hospital of Tübingen , Tübingen, Germany
                [2] 2Department of Anesthesiology and Intensive Care Medicine, Hospital of Bayreuth , Bayreuth, Germany
                Author notes

                Edited by: Fabrice Cognasse, Etablissement Français du Sang Rhône-Alpes-Auvergne and GIMAP EA3064 Université de Lyon, France

                Reviewed by: Saurabh Aggarwal, University of Alabama at Birmingham, United States; Susan M. Bueno, Pontificia Universidad Católica de Chile, Chile

                *Correspondence: Jörg Reutershan, joerg.reutershan@ 123456klinikum-bayreuth.de

                Specialty section: This article was submitted to Inflammation, a section of the journal Frontiers in Immunology

                Article
                10.3389/fimmu.2017.01874
                5742329
                cbc6bca5-b181-49b3-9ece-936610ebe5a1
                Copyright © 2017 Konrad, Zwergel, Ngamsri and Reutershan.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 05 September 2017
                : 08 December 2017
                Page count
                Figures: 7, Tables: 0, Equations: 0, References: 72, Pages: 17, Words: 7896
                Funding
                Funded by: Else Kröner-Fresenius-Stiftung 10.13039/501100003042
                Award ID: 2014_A148
                Categories
                Immunology
                Original Research

                Immunology
                heme oxygenase-1,pulmonary inflammation,neutrophil,pmn,hemin
                Immunology
                heme oxygenase-1, pulmonary inflammation, neutrophil, pmn, hemin

                Comments

                Comment on this article